EMEA Refines Post-Market Renewal Requirements To One Five-Year Review
The European Medicines Agency will require all products to have one review five years after marketing authorization, effective Nov. 20, 2005
The European Medicines Agency will require all products to have one review five years after marketing authorization, effective Nov. 20, 2005